Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al

Cardiovasc Drugs Ther. 2013 Apr;27(2):105-7. doi: 10.1007/s10557-013-6443-3.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / analogs & derivatives*
  • Animals
  • Antibodies / administration & dosage*
  • Male
  • Myocardial Infarction / drug therapy*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Membrane Glycoproteins / immunology*
  • Purinergic P2Y Receptor Antagonists / administration & dosage*

Substances

  • Antibodies
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoproteins
  • Purinergic P2Y Receptor Antagonists
  • platelet membrane glycoprotein VI
  • Adenosine Monophosphate
  • cangrelor